Glinsukon T, Kongsuktrakoon B, Toskulkao C, Sophasan S
Toxicol Lett. 1983 Mar;15(4):341-8. doi: 10.1016/0378-4274(83)90154-6.
In situ glucose absorption in the mouse was significantly inhibited by cytochalasin E. Cytochalasin E (5 micrograms/ml) also inhibited glucose absorption up to 55.5% in mouse jejunum in vitro. During its inhibition transmural potential difference (PD) was increased from -7.4 to -0.4 mV, together with a decrease in glucose accumulation in the intestinal tissues. Furthermore, it was also found that cytochalasin E induced an alteration in Km value from 2.9 X 10(-3) to 4.0 X 10(-2) M and a constant Vmax value of 55.5 mumol/100 mg wet wt tissue/min. It is postulated that cytochalasin E is a possible competitive inhibitor of glucose at the receptor sites of carriers on the microvillar membrane of the intestinal absorptive cells.
细胞松弛素E可显著抑制小鼠的原位葡萄糖吸收。细胞松弛素E(5微克/毫升)在体外也可抑制小鼠空肠的葡萄糖吸收达55.5%。在其抑制过程中,跨膜电位差(PD)从-7.4毫伏增加到-0.4毫伏,同时肠道组织中的葡萄糖积累减少。此外,还发现细胞松弛素E可使米氏常数(Km)值从2.9×10⁻³ 摩尔变为4.0×10⁻² 摩尔,而最大反应速度(Vmax)值恒定为55.5微摩尔/100毫克湿重组织/分钟。据推测,细胞松弛素E可能是肠道吸收细胞微绒毛膜上载体受体部位葡萄糖的竞争性抑制剂。